Total Payments
$26,293
2024 Payments
$4,121
Companies
47
Transactions
1,407
Medicare Patients
10,837
Medicare Billing
$696,183
Payment Breakdown by Category
Food & Beverage$24,028 (91.4%)
Education$664.52 (2.5%)
Consulting$600.00 (2.3%)
Other$500.00 (1.9%)
Research$500.00 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,028 | 1,395 | 91.4% |
| Education | $664.52 | 9 | 2.5% |
| Consulting Fee | $600.00 | 1 | 2.3% |
| Unspecified | $500.00 | 1 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 | 1.9% |
Payments by Type
General
$25,793
1,406 transactions
Research
$500.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,002 | 203 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,705 | 196 | $0 (2024) |
| Janssen Biotech, Inc. | $2,513 | 169 | $0 (2024) |
| Amgen Inc. | $1,654 | 77 | $0 (2024) |
| GENZYME CORPORATION | $1,485 | 66 | $0 (2024) |
| PFIZER INC. | $1,465 | 121 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,262 | 69 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,186 | 58 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,058 | 64 | $0 (2024) |
| UCB, Inc. | $940.45 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,121 | 215 | Janssen Biotech, Inc. ($604.73) |
| 2023 | $3,473 | 175 | Janssen Biotech, Inc. ($608.38) |
| 2022 | $3,430 | 160 | ABBVIE INC. ($616.42) |
| 2021 | $3,516 | 193 | AbbVie Inc. ($877.41) |
| 2020 | $2,582 | 124 | AbbVie Inc. ($552.98) |
| 2019 | $3,992 | 173 | Novartis Pharmaceuticals Corporation ($1,060) |
| 2018 | $2,278 | 159 | Novartis Pharmaceuticals Corporation ($338.57) |
| 2017 | $2,901 | 208 | Promius Pharma LLC ($658.09) |
All Payment Transactions
1,407 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: DERMATOLOGY | ||||||
| 12/23/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $1.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Immunology | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.50 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.47 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Immunology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.24 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROTOPIC APPLES | LEO Pharma AS | $500.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,151 | 3,189 | $321,429 | $123,649 |
| 2022 | 22 | 2,351 | 3,568 | $370,500 | $149,434 |
| 2021 | 28 | 3,102 | 4,792 | $501,379 | $215,875 |
| 2020 | 26 | 3,233 | 5,416 | $533,862 | $207,224 |
Total Patients
10,837
Total Services
16,965
Medicare Billing
$696,183
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 264 | 311 | $31,100 | $16,726 | 53.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 317 | 372 | $37,200 | $13,473 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 161 | $21,735 | $12,557 | 57.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 177 | 192 | $30,720 | $12,032 | 39.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 268 | 316 | $20,540 | $10,999 | 53.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 184 | 342 | $47,880 | $9,201 | 19.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 65 | 76 | $22,800 | $8,210 | 36.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $11,620 | $5,232 | 45.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 121 | 121 | $10,890 | $5,074 | 46.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 63 | 68 | $11,220 | $4,601 | 41.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 54 | 113 | $10,170 | $4,181 | 41.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 227 | 774 | $19,350 | $3,391 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $5,880 | $3,045 | 51.8% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 18 | 23 | $7,383 | $2,886 | 39.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 20 | $5,000 | $2,334 | 46.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 15 | 23 | $5,865 | $1,928 | 32.9% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 16 | 21 | $4,515 | $1,471 | 32.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 16 | $3,120 | $1,275 | 40.9% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 16 | 20 | $3,200 | $1,095 | 34.2% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 18 | 21 | $3,150 | $963.71 | 30.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 11 | $2,090 | $944.10 | 45.2% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 18 | 20 | $2,317 | $892.85 | 38.5% |
| 17260 | Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | Office | 2023 | 13 | 14 | $2,394 | $790.86 | 33.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 43 | $1,290 | $349.80 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 466 | 565 | $55,600 | $30,856 | 55.5% |
About Dr. Marek Stawiski, MD
Dr. Marek Stawiski, MD is a Dermatopathology healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679573331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marek Stawiski, MD has received a total of $26,293 in payments from pharmaceutical and medical device companies, with $4,121 received in 2024. These payments were reported across 1,407 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($24,028).
As a Medicare-enrolled provider, Stawiski has provided services to 10,837 Medicare beneficiaries, totaling 16,965 services with total Medicare billing of $696,183. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Grand Rapids, MI
- Active Since 07/26/2005
- Last Updated 01/22/2014
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1679573331
Products in Payments
- COSENTYX (Biological) $2,958
- DUPIXENT (Biological) $2,010
- SKYRIZI (Biological) $1,855
- Otezla (Drug) $1,711
- TREMFYA (Drug) $1,672
- EUCRISA (Drug) $1,306
- Sotyktu (Drug) $1,137
- ILUMYA (Biological) $886.40
- Enbrel (Biological) $820.36
- SILIQ (Drug) $780.21
- Humira (Biological) $741.50
- Tremfya (Drug) $740.44
- Cimzia (Drug) $727.29
- COSENTYX (Drug) $698.90
- RINVOQ (Biological) $694.96
- TALTZ (Drug) $669.55
- HUMIRA (Biological) $529.31
- PROTOPIC (Drug) $500.00
- Promiseb Complete (Device) $500.00
- DUPIXENT (Drug) $316.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.